Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.
AUTOR(ES)
Stenson, W F
RESUMO
Neutrophils metabolize arachidonic acid through the liposygenase pathway to 5-hydroxy-6,8,11,14-eicosatetrenoic acid (5-HETE) and 5,12-dihydroxy-6,8,10,14-eicosatraenoic acid (5,12 diHETE). 5-HETE and 5,12diHETE are potent chemotactic agents and are thought to have important roles in the inflammatory response. In this study we demonstrate the sulfasalazine, at concentrations found in the stool of patients being treated for ulcerative colitis, blocks the synthesis of both 5-HETE and 5,12 diHETE by human neutrophils. A sulfasalazine metabolite, 5-aminosalicylate, also blocks the synthesis of 5,12 diHETE.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=371000Documentos Relacionados
- Monocyte-chemotactic activity of defensins from human neutrophils.
- Synovial fluid inhibits killing of Staphylococcus aureus by neutrophils.
- Alkalinizing the intralysosomal pH inhibits degranulation of human neutrophils.
- Adhesion protein GMP140 inhibits superoxide anion release by human neutrophils.
- Stimulus-specific deactivation of chemotactic factor-induced cyclic AMP response and superoxide generation by human neutrophils.